What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion

Clinical management of breakthrough cancer pain (BTcP) is still not satisfactory despite the availability of effective pharmacological agents. This is in part linked to the lack of clarity regarding certain essential aspects of BTcP, including terminology, definition, epidemiology and assessment. Ot...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Drugs
Autores principales: Vellucci, R., Fanelli, G., Pannuti, R., Peruselli, C., Adamo, S., Alongi, G., Amato, F., Consoletti, L., Lamarca, L., Liguori, S., Lo Presti, C., Maione, A., Mameli, S., Marinangeli, F., Marulli, S., Minotti, V., Miotti, D., Montanari, L., Moruzzi, G., Palermo, S., Parolini, M., Poli, P., Tirelli, W., Valle, A., Romualdi, P.
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer International Publishing 2016
Materias:
Therapy in Practice
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4757619/
https://ncbi.nlm.nih.gov/pubmed/26755179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-015-0519-2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares